🇺🇸 FDA
Patent

US 11622954

Estrogen receptor ligands, compositions and methods related thereto

granted A61KA61K31/277A61K45/06

Quick answer

US patent 11622954 (Estrogen receptor ligands, compositions and methods related thereto) held by The Regents of the University of California expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/277, A61K45/06, A61P, A61P25/14